Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 3/20 | 0.39 |
| ▸ | CA12 | O43570 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | CA6 | P23280 | 1/20 | 0.39 |
| ▸ | CA5A | P35218 | 1/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | CASP6 | P55212 | 2/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30092607 | 1.00 | LMNA (0.52) | LMNAALDH1A1HSD17B10HDAC6KDM4E | |
| SCHEMBL21497949 | 1.00 | LMNA (0.52) | LMNAALDH1A1HSD17B10HDAC6KDM4E | |
| SCHEMBL21713276 | 0.90 | HDAC6 (0.47) | LMNAALDH1A1HSD17B10HDAC6KDM4E | |
| SCHEMBL29593464 | 0.90 | HDAC6 (0.47) | LMNAALDH1A1HSD17B10HDAC6KDM4E | |
| SCHEMBL20584147 | 0.87 | ALDH1A1 (0.48) | LMNAALDH1A1HSD17B10HDAC6KDM4E | |
| SCHEMBL29460076 | 0.87 | ALDH1A1 (0.48) | LMNAALDH1A1HSD17B10HDAC6KDM4E | |
| SCHEMBL9602182 | 0.85 | HDAC6 (0.51) | LMNAALDH1A1HSD17B10HDAC6KDM4E | |
| SCHEMBL3267891 | 0.85 | ALDH1A1 (0.46) | LMNAALDH1A1HSD17B10HDAC6KDM4E | |
| SCHEMBL29337713 | 0.82 | MYC (0.48) | LMNAALDH1A1HSD17B10HDAC6KDM4E | |
| SCHEMBL29337709 | 0.82 | MYC (0.48) | LMNAALDH1A1HSD17B10HDAC6KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240243319-A1 | AQUEOUS ELECTROLYTE, SALTS USED THEREIN, AND REDOX FLOW BATTERY USING SAID AQUEOUS ELECTROLYTE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-07-18 | — | — | US | disclosed |
| US-20230095542-A1 | Novel Phenazine-Based Compounds | CMBLU ENERGY AG (DE) | 2023-03-30 | — | — | US | disclosed |
| EP-4107147-A1 | NOVEL PHENAZINE-BASED COMPOUNDS | CMBlu Energy AG (DE) | 2022-12-28 | — | — | EP | disclosed |
| WO-2022111833-A1 | ELECTROLYTE REGENERATION FOR ORGANIC REDOX FLOW BATTERIES BASED ON WATER-SOLUBLE PHENAZINE-BASED COMPOUNDS | CMBLU ENERGY AG (DE) | 2022-06-02 | — | — | WO | disclosed |
| US-10454124-B2 | Highly stable phenazine derivatives for aqueous redox flow batteries | BATTELLE MEMORIAL INSTITUTE (US) | 2019-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230095542-A1 | Novel Phenazine-Based Compounds | PRDX5, NDUFS5, GPX4 | LMNA 3410/4885ALDH1A1 906/4885HSD17B10 1328/4885 |
| US-10454124-B2 | Highly stable phenazine derivatives for aqueous redox flow batteries | NDUFS5, NDUFS2, NDUFV1 | LMNA 3971/4885ALDH1A1 207/4885HSD17B10 1277/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.